Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Biora Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative oral biotherapeutic drug-device combination platforms. Its NaviCap platform delivers targeted therapies to the gastrointestinal tract for inflammatory bowel disease, while the BioJet platform enables needle-free, systemic oral delivery of large molecules to replace injections. Biora focuses on improving patient outcomes and convenience by enhancing drug efficacy, safety, and compliance in large, underserved markets through proprietary ingestible devices and formulations.
This description was generated via AI from an annual report. Updated about 1 year ago.